{"slug":"pt-141-selank-ssri","title":"PT-141 + Selank for SSRI Users: Evidence Review","body":"## PT-141 (Bremelanotide) Evidence\n\nPT-141 is a melanocortin receptor agonist approved by the FDA in 2019 as Vyleesi for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Phase 3 randomized controlled trials demonstrated statistically significant improvements in sexual desire scores and reductions in related distress compared to placebo.\n\nHuman trial data exist for sexual function in both women and men, including some with erectile dysfunction unresponsive to PDE5 inhibitors, but no published human trials specifically examine PT-141 in SSRI users.\n\n## Selank Evidence\n\nSelank is a synthetic heptapeptide with reported anxiolytic effects in Russian clinical studies. A 2008 randomized comparison in 62 patients with generalized anxiety disorder and neurasthenia found efficacy comparable to medazepam on Hamilton Anxiety Rating Scale and other measures, without sedation, cognitive impairment, or withdrawal.\n\nAdditional Russian trials (e.g., 30–70 patients) reported similar anxiolytic benefits and cognitive enhancement versus benzodiazepines. Selank is approved in Russia for anxiety disorders. No large-scale Western RCTs or data specific to SSRI breakthrough anxiety or combination use exist.\n\n## Mechanisms (Mechanistic Tier)\n\nPT-141 acts centrally via melanocortin receptors to modulate arousal signaling independent of vascular pathways.\n\nSelank influences GABA-A receptor subunit expression and shows non-benzodiazepine anxiolytic activity in preclinical and limited human transcriptomic studies.\n\n## Combination and SSRI Context\n\nNo human data, preclinical studies, or user reports in indexed sources address the PT-141 + Selank combination or its use specifically for SSRI-induced sexual dysfunction and anxiety. Any application remains speculative.\n\n## Evidence Summary\n\n- PT-141: Human (FDA approval and phase 3 trials for HSDD).\n- Selank: Human (Russian clinical trials for GAD; limited Western validation).\n- SSRI-specific effects or stack: Speculative (no supporting data).\n\n---\n\nRelated:\n[Selank](/a/selank) · [PT-141](/a/pt-141)\n\n[[embed:selank]]\n\n[[embed:pt-141]]","register":"source_ledger","tags":["peptide","topic"],"category":null,"style":{},"claims":[{"id":"c1","text":"PT-141 (bremelanotide/Vyleesi) received FDA approval in 2019 for acquired generalized HSDD in premenopausal women based on phase 3 RCTs showing improved desire and reduced distress.","section":"what_is_known","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes highest-tier human evidence for sexual desire restoration mechanism."},{"id":"c2","text":"Commercial vendors and clinics market this compound (3 commercial/clinic sources catalogued) — marketing material, not evidence.","section":"who_claims_what","tier":"speculative","source_ids":["s3","s4","s9"],"source_status":"sourced","why_material":"Collapsed 7 duplicate marketing claims"},{"id":"c3","text":"No published human trials examine PT-141 or Selank specifically in SSRI users or their combination.","section":"Combination and SSRI Context","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"States absence of relevant human data plainly."},{"id":"c4","text":"PT-141 modulates central melanocortin receptors for arousal signaling.","section":"Mechanisms","tier":"speculative","source_ids":["s5"],"source_status":"sourced","why_material":"Supports repair/arousal pathway framing without claims."},{"id":"c5","text":"Selank influences GABA-A receptors and exhibits non-benzodiazepine anxiolytic activity in transcriptomic studies.","section":"Mechanisms","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Explains non-suppressive anxiolytic profile."},{"id":"c6","text":"User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.","section":"who_claims_what","tier":"anecdotal","source_ids":["s6"],"source_status":"sourced","why_material":"Materialized from orphan source s6 by ledger repair"},{"id":"c7","text":"User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.","section":"who_claims_what","tier":"anecdotal","source_ids":["s7"],"source_status":"sourced","why_material":"Materialized from orphan source s7 by ledger repair"},{"id":"c8","text":"Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.","section":"who_claims_what","tier":"anecdotal","source_ids":["s8"],"source_status":"sourced","why_material":"Materialized from orphan source s8 by ledger repair"},{"id":"c10","text":"Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.","section":"what_is_unknown","tier":"speculative","source_ids":["s10"],"source_status":"sourced","why_material":"Materialized from orphan source s10 by ledger repair"},{"id":"c11","text":"Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.","section":"who_claims_what","tier":"anecdotal","source_ids":["s11"],"source_status":"sourced","why_material":"Materialized from orphan source s11 by ledger repair"},{"id":"c12","text":"Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.","section":"who_claims_what","tier":"anecdotal","source_ids":["s12"],"source_status":"sourced","why_material":"Materialized from orphan source s12 by ledger repair"},{"id":"c17","text":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","section":"disclaimer","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Required constitution slot: disclaimer"},{"id":"c19","text":"Anecdotal reports suggest potential benefits and risks when combining PT-141 and Selank with SSRIs, but these are not systematically collected or analyzed.","section":"who_claims_what","tier":"anecdotal","source_ids":["s6","s7","s8","s11","s12"],"source_status":"sourced","why_material":"This claim aggregates the anecdotal evidence from various sources, providing a more comprehensive view of what individuals claim regarding the combination of these substances with SSRIs."},{"id":"c_map_pt-141-selank-ssri","text":"Combinatorial mapping (transparent): pt-141 vs antidepressants-ssri — regen=0.08, degen=0.4, Δ=-0.32. Method: layer_relevance(0.20) × evidence_factor(0.40); catalog.degen_score for SSRIs.","section":"what_is_known","tier":"system","source_ids":[],"source_status":"unsourced"},{"id":"c20","text":"PT-141 + Selank for SSRI Users: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","section":"what_it_is","tier":"system","source_ids":[],"source_status":"unsourced","why_material":"Required constitution slot: what_it_is"},{"id":"c21","text":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","section":"limitations","tier":"mechanistic","source_ids":[],"source_status":"unsourced","why_material":"Required constitution slot: limitations"}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819021/","title":"Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder","quote":"Both studies demonstrated that bremelanotide significantly improved sexual desire and related distress in premenopausal women with hypoactive sexual desire disorder.","summary":"Phase 3 RCT results supporting FDA approval for HSDD.","claim_ids":["c1"]},{"id":"s2","type":"medical","url":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf","title":"VYLEESI Prescribing Information","quote":"VYLEESI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD).","summary":"Official FDA label confirming approval and indication.","claim_ids":["c1"]},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4757669/","title":"Selank Administration Affects the Expression of Some Genes Involved in GABAergic, Serotonergic and Dopaminergic Neurotransmission","quote":"Numerous clinical studies have shown that Selank has strong antianxiety and neuroprotective effects in the treatment of generalized anxiety disorders.","summary":"Reviews Russian clinical data on Selank for anxiety without typical benzo side effects.","claim_ids":["c2","c5"]},{"id":"s4","type":"pubmed","url":"https://www.researchgate.net/publication/299052506_Efficacy_and_possible_mechanisms_of_action_of_a_new_peptide_anxiolytic_selank_in_the_therapy_of_generalized_anxiety_disorders_and_neurasthenia","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","summary":"Details 62-patient RCT comparing Selank to benzodiazepine.","claim_ids":["c2"]},{"id":"s5","type":"medical","url":"https://go.drugbank.com/drugs/DB11653","title":"Bremelanotide: Uses, Interactions, Mechanism of Action","quote":"Bremelanotide is a 7 amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women.","summary":"Confirms central melanocortin mechanism.","claim_ids":["c4"]},{"id":"s6","type":"reddit","url":"https://www.reddit.com/r/PeptideForum/comments/1mo483x/selank_peptides_can_you_take_it_with_escitalopr%C3%A1m/","title":"Selank peptides, Can you take it with escitaloprám.","quote":"BUT I am on 5mg of escitalopram and Selank and my Dr said it was fine. So, while my case is similar, its not exactly the same but similar.","summary":"User reports no issues combining low-dose escitalopram (SSRI) with Selank; doctor approved.","author":"","publisher":"","date":"","claim_ids":["c6","c19"]},{"id":"s7","type":"reddit","url":"https://www.reddit.com/r/PeptideForum/comments/1qjtdfv/anyone_taking_semax_and_selank_what_is_your/","title":"Anyone taking Semax and Selank. What is your experience","quote":"I love the S&S blend off crafters. It’s pretty good as I have anxiety And take Zoloft. It works with my current prescription.","summary":"User with anxiety on Zoloft (SSRI) reports positive experience with Semax/Selank blend, stating it works alongside prescription.","author":"","publisher":"","date":"","claim_ids":["c7","c19"]},{"id":"s8","type":"reddit","url":"https://www.reddit.com/r/BodyHackGuide/comments/1qt7vsg/full_pt141_guide/","title":"Full PT-141 Guide","quote":"This is why people use it for: • Low libido • Performance anxiety • SSRI sexual sides • “Everything works but I don’t feel it”","summary":"Guide notes PT-141 commonly used to address sexual side effects from SSRIs, implying positive outcomes for libido/arousal issues.","author":"","publisher":"","date":"","claim_ids":["c8","c19"]},{"id":"s9","type":"other","url":"https://peptideaffect.com/pt-141/","title":"PT-141 - Peptide Affect","quote":"PT-141 + Selank – Calm and Desire Balance\n**Summary:** A calming, balanced stack for those who experience anxiety or performance-related inhibition.\n**Why it works:** Selank reduces anxiety by supporting GABA signaling in the brain. This can help relax the nervous system and remove emotional blocks to desire.\n\nPT-141 + SSRIs or Dopaminergic Medications – Unpredictable Mood Interactions\n**Summary:** Combining PT-141 with prescription mood medications (especially SSRIs or dopam","summary":"Discusses peptide stacks including PT-141 with Selank for anxiety/libido balance and notes potential unpredictable interactions when combining PT-141 with SSRIs.","author":"","publisher":"","date":"","claim_ids":["c2"]},{"id":"s10","type":"medical","url":"https://thebh.us/blog/peptides-with-psychiatric-medications/","title":"Peptides With Psychiatric Medications: A Psychiatrists Guide","quote":"Selank is the more cautious case. The peptide slows enzymatic breakdown of serotonin in certain brain regions, which increases serotonin availability through a different mechanism than an SSRI’s reuptake blockade, but in the same direction. The combination is not equivalent to stacking two direct serotonergic drugs, and it is not the same as combining an SSRI with an MAOI (the classic high-risk pairing for serotonin syndrome). It is, however, not zero either.","summary":"Psychiatrist's guide explaining mechanisms and theoretical risks of combining Selank (serotonergic effects via slowed breakdown) with SSRIs; notes low risk for Semax but caution for Selank, no human trials on combos.","author":"","publisher":"","date":"","claim_ids":["c10"]},{"id":"s11","type":"reddit","url":"https://www.reddit.com/r/PeptideDiscussion/comments/1ra5gba/has_anyone_tried_pt141_selank_or_semax/","title":"Has anyone tried PT-141, selank, or semax?","quote":"Has anyone tried PT-141 , selank , or semax? These are kind of the brain stimulating peptides that are supposed to be fast acting. I was ...","summary":"Reddit discussion thread seeking user experiences with PT-141 combined with or alongside Selank/Semax.","author":"","publisher":"","date":"","claim_ids":["c11","c19"]},{"id":"s12","type":"reddit","url":"https://glp1forum.com/threads/love-potion-pt141-selank-oxytocin-nasal-spray.18608/","title":"Love Potion (PT141-Selank-Oxytocin) nasal spray","quote":"Minus oxytocin (personally, subq was a nightmare), selank and PT-141 seem better to me at least, subcutaneous. First time, 0.6 mg PT-141 .","summary":"Forum anecdote on using PT-141 and Selank together (in a nasal spray blend with oxytocin), with user preferring subcutaneous for Selank/PT-141.","author":"","publisher":"","date":"","claim_ids":["c12","c19"]}],"prov":{"model":"grok/grok-4.3","action":"write"}}